Member of the Association of American Physicians
His main research concerns Internal medicine, Endocrinology, Insulin, Insulin resistance and Weight gain. Internal medicine is represented through his Aldosterone, Angiotensin II receptor type 1, Triglyceride, Carbohydrate metabolism and Lipogenesis research. He regularly ties together related areas like Receptor in his Endocrinology studies.
His work in Receptor tackles topics such as Distribution which are related to areas like Renin–angiotensin system. His Insulin study combines topics in areas such as Diabetes mellitus, Streptozotocin and Alpha. As a member of one scientific family, he mostly works in the field of Insulin resistance, focusing on Hyperlipidemia and, on occasion, Lipoprotein and Indinavir.
His primary scientific interests are in Internal medicine, Endocrinology, Aldosterone, Insulin and Renin–angiotensin system. Internal medicine is closely attributed to Diabetes mellitus in his work. His work on Endocrinology is being expanded to include thematically relevant topics such as Receptor.
His Aldosterone study incorporates themes from Essential hypertension, Corticosterone and Hypoaldosteronism. Morris Schambelan has researched Insulin in several fields, including Adipose tissue and Triglyceride. His research in Renin–angiotensin system focuses on subjects like Renal vein, which are connected to Renal infarction and Stenosis.
Morris Schambelan focuses on Internal medicine, Endocrinology, Insulin resistance, Insulin and Carbohydrate metabolism. His work in Internal medicine is not limited to one particular discipline; it also encompasses Hiv infected. In his articles, Morris Schambelan combines various disciplines, including Endocrinology and Lipoatrophy.
His Insulin resistance study deals with Type 2 diabetes intersecting with Glucose tolerance test, C-peptide, Postprandial and Glucagon. Morris Schambelan interconnects Diabetes mellitus and Adipose tissue in the investigation of issues within Insulin. As part of one scientific family, Morris Schambelan deals mainly with the area of Carbohydrate metabolism, narrowing it down to issues related to the Lipogenesis, and often Fructose, Lipid profile and Fatty acid synthesis.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin resistance, Insulin and Carbohydrate metabolism. He brings together Internal medicine and Lipoatrophy to produce work in his papers. His Insulin resistance research incorporates themes from Dyslipidemia and Metreleptin.
As a part of the same scientific family, Morris Schambelan mostly works in the field of Insulin, focusing on Adipose tissue and, on occasion, Insulin receptor, IRS2, Signal transduction, Phosphorylation and Kinase. His Carbohydrate metabolism research includes themes of Fructose, Lipid profile, Lipogenesis and Fatty acid synthesis. His research in Glucose uptake intersects with topics in Gastric inhibitory polypeptide and Pancreatic hormone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel
Richard A. Shimkets;David G. Warnock;Christopher M. Bositis;Carol Nelson-Williams.
Sarcopenia With Limited Mobility: An International Consensus
John E. Morley;Angela Marie Abbatecola;Josep M Argiles;Vickie Baracos.
Journal of the American Medical Directors Association (2011)
“Buffalo hump” in men with HIV-1 infection
Joan C Lo;Kathleen Mulligan;Viva W Tai;Heather Algren.
The Lancet (1998)
Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.
Kathleen Mulligan;Carl Grunfeld;Viva W. Tai;Heather Algren.
Journal of Acquired Immune Deficiency Syndromes (2000)
Growth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability
Maxine A. Papadakis;Deborah Grady;Dennis Black;Mary Jo Tierney.
Annals of Internal Medicine (1996)
Expression of AT2 receptors in the developing rat fetus.
E F Grady;L A Sechi;C A Griffin;M Schambelan.
Journal of Clinical Investigation (1991)
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.
Morris Schambelan;Constance A. Benson;Andrew Carr;Judith S. Currier.
Journal of Acquired Immune Deficiency Syndromes (2002)
Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting: A Randomized, Placebo-Controlled Trial
Morris Schambelan;Kathleen Mulligan;Carl Grunfeld;Eric S. Daar.
Annals of Internal Medicine (1996)
Metabolic effects of indinavir in healthy HIV-seronegative men.
Mustafa A. Noor;Joan C. Lo;Kathleen Mulligan;Jean-Marc Schwarz.
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Kirsten L. Johansen;Kathleen Mulligan;Morris Schambelan.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: